The same lesson over and over: drugs alone will not get us to 90--90--90.
Journal
AIDS (London, England)
ISSN: 1473-5571
Titre abrégé: AIDS
Pays: England
ID NLM: 8710219
Informations de publication
Date de publication:
01 05 2020
01 05 2020
Historique:
pubmed:
7
2
2020
medline:
23
2
2021
entrez:
7
2
2020
Statut:
ppublish
Résumé
: Addressing social determinants of health (SDH) has far greater potential to improve the real-world effectiveness of HIV treatment than expensive, incremental changes in antiretroviral therapy. The ADVANCE study demonstrates that SDH is more impactful than medication regimen on health outcomes. Younger patients and unemployed patients experience heightened precarity, which can have pervasive effects on adherence and suppression. Enhanced adherence counselling can help socioeconomically precarious patients maintain suppression, but in order to improve treatment effectiveness and population health, we should move beyond the short-term solution of helping patients 'cope' with insecurity toward tackling the underlying factors that lead to precarity. Data on intention-to-treat populations are critical to this effort, yet medical researchers and publications continue to obscure the influence of SDH by focusing on per-protocol populations.
Identifiants
pubmed: 32028330
doi: 10.1097/QAD.0000000000002494
pii: 00002030-202005010-00015
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
Langues
eng
Sous-ensembles de citation
IM
Pagination
943-946Références
World Health Organization. About social determinants of health. Available at: https://www.who.int/social_determinants/sdh_definition/en/. [Accessed 9 January 2020]
Venter WDF, Moorhouse M, Sokhela S, Fairlie L, Mashabane N, Masenya M, et al. Dolutegravir plus two different prodrugs of tenofovir to treat HIV. N Engl J Med 2019; 381:803–815.
2019 Q2 (Apr-June) expanded unemployment at 38.5% (p. 7). It is 43% among black South Africans (p. 39). Statistics South Africa. Quarterly Labour Force Survey, Quarter 2, 2019. Available at http://www.statssa.gov.za/publications/P0211/P02112ndQuarter2019.pdf [Accessed 4 February 2020]
Umar E, Levy JA, Bailey RC, Donenberg G, Hershow RC, Mackesy-Amiti ME. Virological nonsuppression and its correlates among adolescents and young people living with HIV in Southern Malawi. AIDS Behav 2019; 23:513–522.
Midtbø V, Shirima V, Skovdal M, Daniel M. How disclosure and antiretroviral therapy help HIV-infected adolescents in sub-Saharan Africa cope with stigma. Afr J AIDS 2012; 11:261–271.
Cluver LD, Hodes RJ, Sherr L, Orkin FM, Meinck F, Lim Ah Ken P, et al. Social protection: potential for improving HIV outcomes among adolescents. J Int AIDS Soc 2015; 18: (Suppl 6): 20260.
Patel S, Abreu M, Tumyan A, Adams-Huet B, Li X, Lingvay I. Effect of medication adherence on clinical outcomes in type 2 diabetes: analysis of the SIMPLE study. BMJ Open Diabetes Res Care 2019; 7:e000761.
Gniwa Omezzine R, Akkara A, Abdelkafi Koubaa A, Belguith Sriha A, Rdissi A, Amamou K. Predictors of poor adherence to hypertension treatment. Tunis Med 2019; 97:564–571.
Forde I, Chandola T, Raine R, Marmot MG, Kivimaki M. Socioeconomic and ethnic differences in use of lipid-lowering drugs after deregulation of simvastatin in the UK: the Whitehall II prospective cohort study. Atherosclerosis 2011; 215:223–228.
Chopra M, Daviaud E, Pattinson R, Fonn S, Lawn JE. Saving the lives of South Africa's mothers, babies, and children: can the health system deliver?. Lancet 2009; 374:835–846.
Rachlis B, Burchell AN, Gardner S, Light L, Raboud J, Antoniou T, et al. Ontario HIV Treatment Network Cohort StudySocial determinants of health and retention in HIV care in a clinical cohort in Ontario, Canada. AIDS Care 2017; 29:828–837.
Ayieko J, Brown L, Anthierens S, Van Rie A, Getahun M, Charlebois ED. Costa AB, et al. ‘Hurdles on the path to 90-90-90 and beyond’: qualitative analysis of barriers to engagement in HIV care among individuals in rural East Africa in the context of test-and-treat. PLoS One 2018; 13:e0202990.
Abela IA, Scherrer AU, Böni J, Yerly S, Klimkait T, Perreau M, et al. Swiss HIV Cohort StudyEmergence of drug resistance in the Swiss HIV cohort study under potent antiretroviral therapy is observed in socially disadvantaged patients. Clin Infect Dis 2019; 70:297–303.
Flynn AG, Anguzu G, Mubiru F, Kiragga AN, Kamya M, Meya DB. De Socio GV, et al. Socioeconomic position and ten-year survival and virologic outcomes in a Ugandan HIV cohort receiving antiretroviral therapy. PLoS One 2017; 12:e0189055.
Burch LS, Smith CJ, Anderson J, Sherr L, Rodger AJ, O’Connell R, et al. Socioeconomic status and treatment outcomes for individuals with HIV on antiretroviral treatment in the UK: cross-sectional and longitudinal analyses. Lancet Public Heal 2016; 1:e26–e36.
International Labour OfficeWorld employment social outlook: trends for women 2018, global snapshot. International Labour Office – Geneva: ILO; 2018.
Cohen J. How the global economic crisis reaches marginalised workers: the case of street traders in Johannesburg, South Africa. Gender Dev 2010; 18:277–289.
Coovadia H, Jewkes R, Barron P, et al. The health and health system of South Africa: historical roots of current public health challenges. Lancet 2009; 374:817–834.